(MedPage Today) -- Patients with colorectal cancer who harbor a mutation in the PIK3CA gene may derive a survival benefit from regular use of aspirin, researchers suggested.
Post a Comment
Aspirin Ups Survival in Some Colon Cancers (CME/CE)
(MedPage Today) — Patients with colorectal cancer who harbor a mutation in the PIK3CA gene may derive a survival benefit from regular use of aspirin, researchers suggested.
Post a Comment
Aspirin Ups Survival in Some Colon Cancers (CME/CE)
(MedPage Today) — Patients with colorectal cancer who harbor a mutation in the PIK3CA gene may derive a survival benefit from regular use of aspirin, researchers suggested.
Post a Comment
Aspirin Ups Survival in Some Colon Cancers (CME/CE)
(MedPage Today) — Patients with colorectal cancer who harbor a mutation in the PIK3CA gene may derive a survival benefit from regular use of aspirin, researchers suggested.